BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1312444)

  • 1. Solubilization of high affinity peptide-YY receptors from porcine brain.
    Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Shii K; Baba S; Balasubramaniam A; Kasuga M
    Endocrinology; 1992 Apr; 130(4):2120-8. PubMed ID: 1312444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of the receptors for avian pancreatic polypeptide in chicken, canine, and pig brains.
    Inui A; Miura M; Teranishi A; Hirosue Y; Nakajima M; Okita M; Nishimura R; Baba S; Kasuga M
    Endocrinology; 1992 Jun; 130(6):3314-22. PubMed ID: 1597144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization and affinity purification of the Y2 receptor for neuropeptide Y and peptide YY from rabbit kidney.
    Sheikh SP; Hansen AP; Williams JA
    J Biol Chem; 1991 Dec; 266(35):23959-66. PubMed ID: 1660889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of peptide YY receptors in the brain.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Shii K; Yokono K; Mizuno N; Baba S
    Endocrinology; 1989 Jan; 124(1):402-9. PubMed ID: 2535812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.
    Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Inoue T; Oya M; Baba S
    Endocrinology; 1990 Aug; 127(2):934-41. PubMed ID: 2164925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain peptide YY receptors: highly conserved characteristics throughout vertebrate evolution.
    Okita M; Inui A; Hirosue Y; Miura M; Nakajima M; Kasuga M
    Endocrinology; 1991 Nov; 129(5):2512-20. PubMed ID: 1657579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization and hydrodynamic properties of active peptide YY receptor from rat jejunal crypts. Characterization as a Mr 44,000 glycoprotein.
    Voisin T; Couvineau A; Rouyer-Fessard C; Laburthe M
    J Biol Chem; 1991 Jun; 266(17):10762-7. PubMed ID: 1645708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of Y1 and Y2 receptors for neuropeptide Y and peptide YY by affinity cross-linking.
    Sheikh SP; Williams JA
    J Biol Chem; 1990 May; 265(14):8304-10. PubMed ID: 2159475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization of the neuropeptide Y receptor from rat brain membranes.
    Mannon PJ; Mervin SJ; Taylor IL
    J Neurochem; 1991 May; 56(5):1804-9. PubMed ID: 1849554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
    Walker MW; Miller RJ
    Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
    Laburthe M; Chenut B; Rouyer-Fessard C; Tatemoto K; Couvineau A; Servin A; Amiranoff B
    Endocrinology; 1986 May; 118(5):1910-7. PubMed ID: 3009142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
    Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization of active somatostatin receptors from rat brain.
    He HT; Rens-Domiano S; Martin JM; Law SF; Borislow S; Woolkalis M; Manning D; Reisine T
    Mol Pharmacol; 1990 May; 37(5):614-21. PubMed ID: 1971088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of neuropeptide Y (NPY) receptors in human hippocampus.
    Li W; Hexum TD
    Brain Res; 1991 Jul; 553(1):167-70. PubMed ID: 1657277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and partial purification of somatostatin-28 preferring receptors from hamster pancreatic beta cells.
    Maletti M; Andersson M; Marie JC; Rosselin G; Mutt V
    J Biol Chem; 1992 Aug; 267(22):15620-5. PubMed ID: 1353498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y (NPY) and peptide YY (PYY) receptors in rat brain.
    Ohkubo T; Niwa M; Yamashita K; Kataoka Y; Shigematsu K
    Cell Mol Neurobiol; 1990 Dec; 10(4):539-52. PubMed ID: 1965425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y receptor binding sites in rat brain: differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity.
    Lynch DR; Walker MW; Miller RJ; Snyder SH
    J Neurosci; 1989 Aug; 9(8):2607-19. PubMed ID: 2549216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.